At a glance
ClinicalIndex Comparison RecordN/ACompleted· 18 enrolled
Drug / intervention
Carbidopa-Levodopadrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Pilot Study of the Drug Effects on Brain Connectivity of Parkinson's Disease
In Brief
A clinical study evaluating Carbidopa-Levodopa for Parkinson's Disease. Completed, enrolled 18 participants across 1 site.
Detailed Summary
Based on studies showing better responsiveness of motor versus cognitive symptoms to Parkinson's Disease medication, also known as dopaminergic treatments, the investigators hypothesize that comparison of resting state networks in the on versus off medication state in Parkinson's Disease patients will show greater effects on brain networks associated with motor control.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsParkinson's Disease
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJun 2011
First PostedFeb 2012
Primary CompletionJul 2012
TodayJul 2026
First PostedFeb 8, 2012
Enrollment StartJun 1, 2011
Primary CompletionJul 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 14.4 years ago
Interventions
Carbidopa-Levodopadrug
Equivalent amount of carbidopa-levodopa will be provide to you